Ethyl 2-bromohexanoate, 95.0%, 25g

3-BROMO-2-CHLOROBENZYL ALCOHOL, 95.0%, 10g

Oxyde de praséodyme en poudre 99,9% 100 g

4,7,10,13,16,19-Hexaoxaheneicosanoic acid, 21-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-, 2,5-dioxo-1-pyrrolidinyl ester, 98%, 1g

N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide, 98%, 10mg

2-Bromonicotinaldehyde>98.0%(GC)5g

Thalidomide-O-amido-C6-NH2 (TFA), 100mg

1-(2-Fluoroethyl)piperidin-4-amine dihydrochloride, 95.0%, 250mg

5-Amino-2-chlorobenzotrifluoride>98.0%(GC)(T)25g

(butan-2-yl)[(3-fluorophenyl)methyl]amine, 95.0%, 10g

3-(Aminosulfonyl)propanoic acid, 95.0%, 5g

1-((4-(2-Methoxyphenoxy)phenyl)sulfonamido)cyclohexane-1-carboxylic acid, 97%, 100mg

2-Chloro-5-methoxy-pyrimidin-4-ylamine, 95.0%, 10g